Spectral CT Clinical Trial

Philips

Status: Terminated

Conditions: Adult ALL

Treatments: Radiation: Spectral CT scanning

Study type: Interventional

Funder types: Industry

Identifiers

NCT05361356

PD_CT_Hawk_2021_11257

Details and patient eligibility

About

The objective of this clinical trial was to evaluate the efficacy, ease of operation, stability, and safety of Spectral CT as expected.

Full description

Under the premise of protecting subjects and ensuring the scientific nature of this clinical trial, Spectral CT was evaluated for its effectiveness, convenience, stability and safety under normal conditions by collecting clinical cases.

Enrollment: 56 patients

Sex: All

Ages: 18 to 75 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Volunteers (ages 18 to 75);
• Negative pregnancy tests for women of childbearing age;
• Agree to participate in the clinical trial and sign the subject informed consent form;
• Enhanced scan requires laboratory evidence of normal renal function.

Exclusion criteria

• The body cannot comply with CT examination;
• Pregnant and lactating women;
• Claustrophobia;
• People who are not suitable for enhanced scanning with iodine contrast agent (previous severe heart failure and hyperthyroidism, iodine contrast agent allergy and susceptibility);
• Patients deemed unsuitable for participation in this clinical trial by the investigator.

Trial design

Primary purpose: Diagnostic

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

56 participants in 1 patient group

Experimental group, all volunteer will be scanned.

Experimental group

Description:

All participation accept Spectral CT scanning; No group;

Treatment:

Radiation: Spectral CT scanning